0001209191-21-051915.txt : 20210817 0001209191-21-051915.hdr.sgml : 20210817 20210817170136 ACCESSION NUMBER: 0001209191-21-051915 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210813 FILED AS OF DATE: 20210817 DATE AS OF CHANGE: 20210817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ramakrishnan Ramesh CENTRAL INDEX KEY: 0001845434 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40047 FILM NUMBER: 211183575 MAIL ADDRESS: STREET 1: 230 CONSTITUTION DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Talis Biomedical Corp CENTRAL INDEX KEY: 0001584751 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 230 CONSTITUTION DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-433-3000 MAIL ADDRESS: STREET 1: 230 CONSTITUTION DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: SlipChip Corp DATE OF NAME CHANGE: 20130820 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-13 1 0001584751 Talis Biomedical Corp TLIS 0001845434 Ramakrishnan Ramesh C/O TALIS BIOMEDICAL CORPORATION 230 CONSTITUTION DRIVE MENLO PARK CA 94025 0 0 0 1 Former Officer Common Stock 2021-08-13 4 M 0 43614 1.50 A 57380 D Common Stock 2021-08-13 4 M 0 8741 1.50 A 66121 D Common Stock 2021-08-13 4 S 0 27502 7.66 D 38619 D Stock Option (right to buy) 1.50 2021-08-13 4 M 0 43614 0.00 D 2021-08-14 Common Stock 43614 0 D Stock Option (right to buy) 1.50 2021-08-13 4 M 0 8741 0.00 D 2021-08-14 Common Stock 8471 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price. 1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date. 25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months. /s/ J. Roger Moody, Jr., Attorney-in-Fact for Ramesh Ramakrishnan 2021-08-17